A collaborative investigation among experts in Alzheimer's disease and multiple sclerosis (MS) finds evidence that MS patients are less likely to have amyloid plaques, a hallmark of Alzheimer's ...
Scientists have found evidence in mice and human brain tissue that the drug ponesimod can reduce inflammation and toxic amyloid plaques common in Alzheimer's. Reading time 2 minutes An existing ...
G protein-coupled receptor 183 (GPR183/EBI2) is one of the key regulators of the innate immune system, and it has been shown to be upregulated in multiple sclerosis (MS) plaques. In a recently ...
Multiple sclerosis (MS) is an autoimmune disease of the brain and spinal cord that can cause problems with movement, muscle function, vision, and cognition. When a person has MS, their immune system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback